December 17, 2008 We are pleased to announce that the FDA has given approval to the application for a Phase I trial of an investigational new drug for the biotherapy cancer treatment. The initial trial will be with a small number of patients and has a primary purpose of establishing safety of the treatment. After … More
October 14, 2010 An important review article in Nature acknowledged the seminal contribution of Dr. Leonard and Dr. Saltzman’s laboratory to the rapidly evolving field of bacterial cancer therapy. See the sentence: “Reports describing Il-2 delivery by Salmonella were the first to suggest that this genus could be effectively used as an anticancer agent (73, … More
May 15, 2008 We are very proud to announce that the National Institutes of Health just awarded a large federal grant to the laboratory of researchers Dr. Arnold Leonard and Dr. Dan Saltzman. The grant has been awarded to their bioengineering lab at the University of Minnesota which is working on a genetically engineered cancer … More